DE69518322T2 - C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel - Google Patents

C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel

Info

Publication number
DE69518322T2
DE69518322T2 DE69518322T DE69518322T DE69518322T2 DE 69518322 T2 DE69518322 T2 DE 69518322T2 DE 69518322 T DE69518322 T DE 69518322T DE 69518322 T DE69518322 T DE 69518322T DE 69518322 T2 DE69518322 T2 DE 69518322T2
Authority
DE
Germany
Prior art keywords
amid
therapeutic agent
substituted compounds
substituted
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69518322T
Other languages
English (en)
Other versions
DE69518322D1 (de
Inventor
A K K Vong
M Thompson
John M Evans
H K A Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411636A external-priority patent/GB9411636D0/en
Priority claimed from GB9411797A external-priority patent/GB9411797D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE69518322D1 publication Critical patent/DE69518322D1/de
Application granted granted Critical
Publication of DE69518322T2 publication Critical patent/DE69518322T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69518322T 1994-06-10 1995-06-09 C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel Expired - Fee Related DE69518322T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9411636A GB9411636D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411797A GB9411797D0 (en) 1994-06-13 1994-06-13 Novel compounds
PCT/EP1995/002249 WO1995034547A1 (en) 1994-06-10 1995-06-09 C-4 amide substituted compounds and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
DE69518322D1 DE69518322D1 (de) 2000-09-14
DE69518322T2 true DE69518322T2 (de) 2001-02-15

Family

ID=26305045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69518322T Expired - Fee Related DE69518322T2 (de) 1994-06-10 1995-06-09 C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel

Country Status (5)

Country Link
US (1) US5843989A (de)
EP (1) EP0764159B1 (de)
JP (1) JPH10501256A (de)
DE (1) DE69518322T2 (de)
WO (1) WO1995034547A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
DE60206505T2 (de) 2001-06-25 2006-07-06 Nissan Chemical Industries, Ltd. Substituierte benzopyranderivate gegen arrhytmie
EP1511734B1 (de) * 2002-04-17 2010-06-23 Cytokinetics, Inc. Verbindungen, zusammensetzungen und verfahren
WO2004006865A2 (en) * 2002-07-17 2004-01-22 Cytokinetics, Inc. Compounds, compositions, and methods
EP1554265A4 (de) * 2002-09-13 2008-05-07 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren
US20050165089A1 (en) * 2003-10-06 2005-07-28 Gustave Bergnes Compounds, compositions and methods
NZ585606A (en) * 2004-03-23 2011-11-25 Nissan Chemical Ind Ltd Tricyclic benzopyran compound as anti-arrhythmic agents
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
CA2961894C (en) 2014-09-19 2023-12-12 Memorial Sloan-Kettering Cancer Center Methods for treating brain metastatis using gap junction inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319772A (en) * 1969-06-18 1973-06-06 Geistlich Soehne Ag Succinimides
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5624954A (en) * 1991-06-13 1997-04-29 Smithkline Beecham P.L.C. Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
PT673374E (pt) * 1992-12-11 2000-07-31 Smithkline Beecham Plc Composicao farmaceutica contendo compostos do tipo biciclico
KR100326968B1 (ko) * 1992-12-11 2002-07-27 스미스클라인비이참피이엘시이 약학적 활성을 가진 이환식 화합물

Also Published As

Publication number Publication date
WO1995034547A1 (en) 1995-12-21
EP0764159A1 (de) 1997-03-26
DE69518322D1 (de) 2000-09-14
EP0764159B1 (de) 2000-08-09
JPH10501256A (ja) 1998-02-03
US5843989A (en) 1998-12-01

Similar Documents

Publication Publication Date Title
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
ATE193298T1 (de) Therapeutische verbindungen
DE59510297D1 (de) Biotinsilan-Verbindungen und diese Verbindungen enthaltende Bindematrix
DE69404382D1 (de) Urea-Derivate und ihre Verwendung als ACAT-hemmenden Verbindungen
DE59408401D1 (de) Polymerisierbare chirale verbindungen und deren verwendung
DE69519189T2 (de) Verschluss, Prozesskartusche und Bilderzeugungsgerät
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE69525113T2 (de) Kopfpositioniervorrichtung und diese enthaltende Platteneinheit
ATE211469T1 (de) Benzopyrans und deren verwendung als therapeutische mittel
DE69518322T2 (de) C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel
ATE267196T1 (de) Sulfonylbenzolverbindungen als analgetische und entzündungshemmende mittel
DE69519368D1 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
DE69500575T2 (de) Neue Sonnenschutzfilter, diese enthaltende kosmetische Sonnenschutzmittel und deren Verwendungen
ATE221037T1 (de) 1,4-diaryl-2-fluoro-2-butene als insectizide und akarizide mittel
ATE220393T1 (de) Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
DE59408191D1 (de) Cyclische Verbindungen und ihre Anwendung als Riechstoffe
DE69512965T2 (de) Metallorganische Verbindungen und deren Verwendung
TR199501553A2 (tr) Sefem bilesimleri ve bunlarin farmasötik olarak kullanilmasi.
DE69021304D1 (de) Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
DE69535697D1 (de) Dihydrobenzofurane und verwandte verbindungen als entzündungshemmende mittel
DE69513225T2 (de) Insektizide und akarizide Mittel
ATE192428T1 (de) Nitro-benzamides verwendbar als antiarrythmica
DE59609913D1 (de) Piperidinylmethyloxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als ZNS wirksame Verbindungen
DE69528261D1 (de) Benzopyrane und deren verwendung als therapeutische mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee